Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Emergence of ceftazidime-avibactam-resistant Klebsiella pneumoniae during treatment, Finland, December 2018.

Räisänen K, Koivula I, Ilmavirta H, Puranen S, Kallonen T, Lyytikäinen O, Jalava J.

Euro Surveill. 2019 May;24(19). doi: 10.2807/1560-7917.ES.2019.24.19.1900256.

2.

Diversification of Colonization Factors in a Multidrug-Resistant Escherichia coli Lineage Evolving under Negative Frequency-Dependent Selection.

McNally A, Kallonen T, Connor C, Abudahab K, Aanensen DM, Horner C, Peacock SJ, Parkhill J, Croucher NJ, Corander J.

MBio. 2019 Apr 23;10(2). pii: e00644-19. doi: 10.1128/mBio.00644-19.

3.

Genomic analysis of Klebsiella pneumoniae isolates from Malawi reveals acquisition of multiple ESBL determinants across diverse lineages.

Musicha P, Msefula CL, Mather AE, Chaguza C, Cain AK, Peno C, Kallonen T, Khonga M, Denis B, Gray KJ, Heyderman RS, Thomson NR, Everett DB, Feasey NA.

J Antimicrob Chemother. 2019 May 1;74(5):1223-1232. doi: 10.1093/jac/dkz032.

4.

The first human report of mobile colistin resistance gene, mcr-1, in Finland.

Gröndahl-Yli-Hannuksela K, Lönnqvist E, Kallonen T, Lindholm L, Jalava J, Rantakokko-Jalava K, Vuopio J.

APMIS. 2018 May;126(5):413-417. doi: 10.1111/apm.12834.

PMID:
29696722
5.

Whole genome sequencing of ESBL-producing Escherichia coli isolated from patients, farm waste and canals in Thailand.

Runcharoen C, Raven KE, Reuter S, Kallonen T, Paksanont S, Thammachote J, Anun S, Blane B, Parkhill J, Peacock SJ, Chantratita N.

Genome Med. 2017 Sep 6;9(1):81. doi: 10.1186/s13073-017-0471-8.

6.

Longitudinal genomic surveillance of multidrug-resistant Escherichia coli carriage in a long-term care facility in the United Kingdom.

Brodrick HJ, Raven KE, Kallonen T, Jamrozy D, Blane B, Brown NM, Martin V, Török ME, Parkhill J, Peacock SJ.

Genome Med. 2017 Jul 25;9(1):70. doi: 10.1186/s13073-017-0457-6.

7.

Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131.

Kallonen T, Brodrick HJ, Harris SR, Corander J, Brown NM, Martin V, Peacock SJ, Parkhill J.

Genome Res. 2017 Jul 18. doi: 10.1101/gr.216606.116. [Epub ahead of print]

8.

Genomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting.

Musicha P, Feasey NA, Cain AK, Kallonen T, Chaguza C, Peno C, Khonga M, Thompson S, Gray KJ, Mather AE, Heyderman RS, Everett DB, Thomson NR, Msefula CL.

J Antimicrob Chemother. 2017 Jun 1;72(6):1602-1609. doi: 10.1093/jac/dkx058.

9.

Bach2 regulates AID-mediated immunoglobulin gene conversion and somatic hypermutation in DT40 B cells.

Budzyńska PM, Kyläniemi MK, Kallonen T, Soikkeli AI, Nera KP, Lassila O, Alinikula J.

Eur J Immunol. 2017 Jun;47(6):993-1001. doi: 10.1002/eji.201646895. Epub 2017 Apr 11.

10.

EPEC: a cocktail of virulence.

Kallonen T, Boinett CJ.

Nat Rev Microbiol. 2016 Apr;14(4):196. doi: 10.1038/nrmicro.2016.33. Epub 2016 Mar 7.

PMID:
26949047
11.

Looking at Beijing's skyline.

Jamrozy D, Kallonen T.

Nat Rev Microbiol. 2015 Sep;13(9):528. No abstract available.

PMID:
26505047
12.

Whole-genome sequencing reveals the effect of vaccination on the evolution of Bordetella pertussis.

Xu Y, Liu B, Gröndahl-Yli-Hannuksila K, Tan Y, Feng L, Kallonen T, Wang L, Peng D, He Q, Wang L, Zhang S.

Sci Rep. 2015 Aug 18;5:12888. doi: 10.1038/srep12888.

13.

Proviral integration site for Moloney murine leukemia virus (PIM) kinases promote human T helper 1 cell differentiation.

Tahvanainen J, Kyläniemi MK, Kanduri K, Gupta B, Lähteenmäki H, Kallonen T, Rajavuori A, Rasool O, Koskinen PJ, Rao KV, Lähdesmäki H, Lahesmaa R.

J Biol Chem. 2013 Feb 1;288(5):3048-58. doi: 10.1074/jbc.M112.361709. Epub 2012 Dec 3.

14.

Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.

Barkoff AM, Gröndahl-Yli-Hannuksela K, Vuononvirta J, Mertsola J, Kallonen T, He Q.

Vaccine. 2012 Nov 6;30(48):6897-902. doi: 10.1016/j.vaccine.2012.09.003. Epub 2012 Sep 13.

PMID:
22981763
15.

Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR.

Kallonen T, Mertsola J, Mooi FR, He Q.

Clin Microbiol Infect. 2012 Oct;18(10):E377-9. doi: 10.1111/j.1469-0691.2012.04000.x. Epub 2012 Aug 22.

16.

Molecular typing of Bordetella parapertussis isolates circulating in Pakistan.

Bokhari H, Said F, Syed MA, Mughal A, Kazi YF, Kallonen T, He Q, King AJ, Heuvelman K, Mooi FR.

FEMS Immunol Med Microbiol. 2011 Dec;63(3):373-80. doi: 10.1111/j.1574-695X.2011.00861.x. Epub 2011 Oct 3.

17.

Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries.

Kallonen T, Gröndahl-Yli-Hannuksela K, Elomaa A, Lutyńska A, Fry NK, Mertsola J, He Q.

Infect Genet Evol. 2011 Dec;11(8):2034-42. doi: 10.1016/j.meegid.2011.09.012. Epub 2011 Sep 21.

PMID:
21964035
18.

SNP-based typing: a useful tool to study Bordetella pertussis populations.

van Gent M, Bart MJ, van der Heide HG, Heuvelman KJ, Kallonen T, He Q, Mertsola J, Advani A, Hallander HO, Janssens K, Hermans PW, Mooi FR.

PLoS One. 2011;6(5):e20340. doi: 10.1371/journal.pone.0020340. Epub 2011 May 27.

19.

Effect of vaccination on Bordetella pertussis strains, China.

Zhang L, Xu Y, Zhao J, Kallonen T, Cui S, Xu Y, Hou Q, Li F, Wang J, He Q, Zhang S.

Emerg Infect Dis. 2010 Nov;16(11):1695-701. doi: 10.3201/eid1611.100401.

20.

Bordetella pertussis vaccine strains and circulating isolates in Serbia.

Dakic G, Kallonen T, Elomaa A, Pljesa T, Vignjevic-Krastavcevic M, He Q.

Vaccine. 2010 Feb 3;28(5):1188-92. doi: 10.1016/j.vaccine.2009.11.036. Epub 2009 Nov 27.

PMID:
19945417
21.

Bordetella pertussis strain variation and evolution postvaccination.

Kallonen T, He Q.

Expert Rev Vaccines. 2009 Jul;8(7):863-75. doi: 10.1586/erv.09.46. Review.

PMID:
19538113
22.

PRELI is a mitochondrial regulator of human primary T-helper cell apoptosis, STAT6, and Th2-cell differentiation.

Tahvanainen J, Kallonen T, Lähteenmäki H, Heiskanen KM, Westermarck J, Rao KV, Lahesmaa R.

Blood. 2009 Feb 5;113(6):1268-77. doi: 10.1182/blood-2008-07-166553. Epub 2008 Oct 22.

PMID:
18945965
23.

Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains.

Heikkinen E, Kallonen T, Saarinen L, Sara R, King AJ, Mooi FR, Soini JT, Mertsola J, He Q.

PLoS One. 2007 Sep 19;2(9):e904.

24.

Enrichment of nucleofected primary human CD4+ T cells: a novel and efficient method for studying gene function and role in human primary T helper cell differentiation.

Tahvanainen J, Pykäläinen M, Kallonen T, Lähteenmäki H, Rasool O, Lahesmaa R.

J Immunol Methods. 2006 Mar 20;310(1-2):30-9. Epub 2006 Feb 8.

PMID:
16516225

Supplemental Content

Loading ...
Support Center